Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan;15(1):53-60.
doi: 10.1016/j.sapharm.2018.03.002. Epub 2018 Mar 6.

Understanding older adults' medication decision making and behavior: A study on over-the-counter (OTC) anticholinergic medications

Affiliations

Understanding older adults' medication decision making and behavior: A study on over-the-counter (OTC) anticholinergic medications

Richard J Holden et al. Res Social Adm Pharm. 2019 Jan.

Abstract

Background: Older adults purchase and use over-the-counter (OTC) medications with potentially significant adverse effects. Some OTC medications, such as those with anticholinergic effects, are relatively contraindicated for use by older adults due to evidence of impaired cognition and other adverse effects.

Objective: To inform the design of future OTC medication safety interventions for older adults, this study investigated consumers' decision making and behavior related to OTC medication purchasing and use, with a focus on OTC anticholinergic medications.

Methods: The study had a cross-sectional design with multiple methods. A total of 84 adults participated in qualitative research interviews (n = 24), in-store shopper observations (n = 39), and laboratory-based simulated OTC shopping tasks (n = 21). Simulated shopping participants also rank-ordered eight factors on their importance for OTC decision making.

Results: Findings revealed that many participants had concerns about medication adverse effects, generally, but were not aware of age-related risk associated with the use of anticholinergic medications. Analyses produced a map of the workflow of OTC-related behavior and decision making as well as related barriers such as difficulty locating medications or comparing them to an alternative. Participants reported effectiveness, adverse effects or health risks, and price as most important to their OTC medication purchase and use decisions. A persona analysis identified two types of consumers: the habit follower, who frequently purchased OTC medications and considered them safe; and the deliberator, who was more likely to weigh their options and consider alternatives to OTC medications.

Conclusion: A conceptual model of OTC medication purchase and use is presented. Drawing on study findings and behavioral theories, the model depicts dual processes for OTC medication decision making - habit-based and deliberation-based - as well as the antecedents and consequences of decision making. This model suggests several design directions for consumer-oriented interventions to promote OTC medication safety.

Keywords: Anticholinergic medications; Decision making; Elderly; Mixed methods; Over-the-counter medication; User-centered design.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
A participant performs the simulated shopping task. Participant is seen comparing packages of two over-the-counter (OTC) medications.
Fig. 2.
Fig. 2.
Flow of OTC medication purchase and use and barriers therein. Components of this figure were identified from in-store observations, and reported by participants during contextual inquiry and simulated shopping sessions.
Fig. 3.
Fig. 3.
Conceptual model of OTC medication decision making and behavior.

Similar articles

Cited by

References

    1. Institute of Medicine. Cognitive Aging: Progress in Understanding and Opportunities for Action Washington, DC: National Academies Press; 2015. - PubMed
    1. Han L, Agostini JV, Allore HG. Cumulative anticholinergic exposure is associated with poor memory and executive function in older men. J Am Geriatr Soc. 2008;56(12):2203–2210. - PMC - PubMed
    1. Katz IR. What should we do about undertreatment of late life psychiatric disorders in primary care? J Am Geriatr Soc. 1998;46(12):1573–1575 published Online First: 1998/12/16. - PubMed
    1. Turner C, Handford AD, Nicholson AN. Sedation and memory: studies with a histamine H-1 receptor antagonist. J PsychopharmacoL 2006;20(4):506–517. 10.1177/0269881106059804 published Online First: 2006/01/13. - DOI - PubMed
    1. Kay G, Crook T, Rekeda L, et al. Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects. Eur UroL. 2006;50(2):317–326. http://dx.doi.org/10.10167j.eururo.2006.03.057 published Online First: 2006/05/12. - PubMed

Publication types

Substances